- Home
- GTE vs TSVT Comparison
GTE vs TSVT Comparison
Compare GTE & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTE
- TSVT
- Stock Information
- Founded
- GTE 2003
- TSVT 2021
- Country
- GTE Canada
- TSVT United States
- Employees
- GTE N/A
- TSVT N/A
- Industry
- GTE Oil & Gas Production
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- GTE Energy
- TSVT Health Care
- Exchange
- GTE Nasdaq
- TSVT Nasdaq
- Market Cap
- GTE 253.1M
- TSVT 253.9M
- IPO Year
- GTE N/A
- TSVT N/A
- Fundamental
- Price
- GTE $6.61
- TSVT $5.01
- Analyst Decision
- GTE Hold
- TSVT Buy
- Analyst Count
- GTE 1
- TSVT 6
- Target Price
- GTE $10.00
- TSVT $10.40
- AVG Volume (30 Days)
- GTE 306.8K
- TSVT 321.7K
- Earning Date
- GTE 10-29-2024
- TSVT 11-12-2024
- Dividend Yield
- GTE N/A
- TSVT N/A
- EPS Growth
- GTE 7.45
- TSVT N/A
- EPS
- GTE 1.56
- TSVT N/A
- Revenue
- GTE $658,051,000.00
- TSVT $44,120,000.00
- Revenue This Year
- GTE $11.16
- TSVT N/A
- Revenue Next Year
- GTE $20.54
- TSVT $22.42
- P/E Ratio
- GTE $4.21
- TSVT N/A
- Revenue Growth
- GTE 3.94
- TSVT N/A
- 52 Week Low
- GTE $4.72
- TSVT $1.54
- 52 Week High
- GTE $10.40
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- GTE 49.84
- TSVT 57.72
- Support Level
- GTE $6.20
- TSVT $4.60
- Resistance Level
- GTE $6.94
- TSVT $4.90
- Average True Range (ATR)
- GTE 0.32
- TSVT 0.31
- MACD
- GTE 0.09
- TSVT 0.01
- Stochastic Oscillator
- GTE 62.92
- TSVT 98.16
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. It is engaged in the acquisition, exploration, development, and production of oil and gas properties. The firm produces light crude oil, supplemented with medium crude and natural gas. Gran Tierra holds interests in producing and prospective properties in Colombia and prospective properties in Ecuador. The company derives its revenue from Colombia.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.